Fig. 5From: Dosimetric parameters and absolute monocyte count can predict the prognosis of acute hematologic toxicity in cervical cancer patients undergoing concurrent chemotherapy and volumetric-modulated arc therapyReceiver operating characteristic (ROC) curves for any grade ≥ 3 hematologic toxicity as a function of TPB_V20Back to article page